A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental study, pharmacological inhibition of an enzyme that plays a central role in ...
It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...
Coherus BioSciences, Inc. ("Coherus,” NASDAQ: CHRS) today announced that an abstract highlighting final clinical and biomarker data from its Phase 2 clinical trial evaluating casdozokitug (casdozo), a ...
Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be ...
A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback